In adults, one-haplotype-mismatched haematopoietic SCT (haploidentical HSCT) is associated with slow immune recovery due to decaying thymic function and extensive T-cell depletion of the graft. Although essential for preventing GVHD, T-cell depletion underlies the major reasons for transplant failure: leukemia relapse and infections, with infection-related mortality accounting for about 40% of non-leukemic deaths. Adoptive T-cell therapy would be helpful for these patients but to administer it without causing GVHD, alloreactive T cells need to be eliminated from donor T lymphocytes before infusion. In a preclinical study, to address this problem, we determined the efficacy of photodynamic purging of alloreactive T cells, by investigating combinations of parameters in order to achieve maximum allodepletion, preservation of T-regulatory cells and of pathogen and leukemia-specific T-cell responses in donor-vs-recipient MLR. We also needed to identify an optimal method to quantify the Ag-specific T-cell repertoires. Optimal procedures were identified. In particular, we compared limiting-dilution analyses (LDA) of proliferating T cells with H 3 -thymidine incorporation by bulk T cells and with flow cytometry CD25 expression, which is accepted as a T-cell activation marker. This study demonstrated that LDA is a reliable, predictable and sensitive method for measuring alloreactive, pathogen-and leukemia-specific T-cell frequencies.
INTRODUCTION
The only option for patients with high-risk acute leukemia who urgently need transplantation but who do not have matched sibling or unrelated donors is transplantation of very high doses of extensively T-cell-depleted peripheral blood hematopoietic stem cells from HLA haplotype-mismatched ('haploidentical') family members. 1 --3 Allogeneic HSCT cures leukemia through the action of donor T cells that promote engraftment, eradicate malignant cells (GVL effect) and reconstitute immunity. Although extensive T-cell depletion prevents GVHD in transplantation across the HLA barrier, 1 --3 it constitutes the main reason for transplant failure.
--3
The 40% infection-related mortality is caused by slow recovery of functional T-cell immunity to pathogens, conditioning regimenrelated thymic damage and age-related thymic involution, which lead to decreased thymic cellularity, marked alterations in the thymic micro-environment, poor naïve T-cell output and restricted repertoires. 4 --7 Even though transferring donor T cells after transplantation could hasten immune reconstitution, the high risk of GVHD is the main obstacle.
Attempts to develop non-alloreactive T-cell infusions by ex vivo induction of allo-Ag anergy or by anti-CD25 immunotoxin were associated with 30% 4grade-I acute GVHD and significant infection-related mortality. 8, 9 An innovative approach is photodynamic purging of alloreactive T cells by means of 4,5-dibromorhodamine methyl ester (TH9402) (Kiadis Pharma, Amsterdam, the Netherlands), a photosensitizer that is similar in structure to rhodamine. When donor T cells are activated with allogeneic cells in vitro, they retain TH9402, which becomes highly cytotoxic when exposed to a fluorescent-light scanning device (Kiadis Pharma). This method demonstrated that alloreactive T cells were selectively eliminated, as anti-third party, anti-CMV T-cell responses and T-regulatory cell content were preserved in vitro in matched and mismatched pair MLRs. 10, 11 When mice in an allogeneic BMT model were infused with photoallodepleted donor T cells, the GVL effect was preserved without GVHD. 12 In order to apply photodynamic purging of alloreactive T cells in the human haploidentical transplant setting, we investigated and reported a range of experimental conditions for optimal T-cell allodepletion with preservation of pathogen-specific responses and T-regulatory cells. 13 Traditional assays for measuring alloreactive and Ag-specific T-cell repertoires were not suitable for our model because they lacked sensitivity and quantification. In a large cohort of matched and mismatched donor--recipient pairs, we demonstrate the simple, reproducible procedure preserved and reliably measured alloreactive, pathogen-and leukemia-specific T-cell repertoires. This evidence was needed to ensure the safety and efficacy of photodynamic purging in the human SCT setting.
MATERIALS AND METHODS

Cell collection
Before G-CSF mobilization, donors and patients underwent a steady-state large-volume leukapheresis to obtain cells and autologous plasma for MLR. Before blood sample collections, donors and patients provided informed consent, in accordance with the Helsinki Declaration.
Donor-plasma processing
Donor plasma was collected during leukapheresis, centrifuged at 3000 r.p.m. for 20 min and then heat inactivated at 56 1C for 30 min.
Plasma was centrifuged again at 2000 r.p.m. for 15 min and filtered with 0.2 m filters.
Photodynamic depletion of alloreactive T cells
Donor PBMC were cultured with 20 Gy irradiated recipient PBMC in T-75 culture flasks (ratios 1:1 or 2:1) in RPMI-1640 medium containing 10% donor defibrinated plasma (responder cell concentration: 3 --5 Â 10 6 /mL; thickness: 0.5 cm; volume: 37.5 mL for each flask). After culture times ranging from 1 to 5 days, cells were phenotyped for CD4, CD8, CD3 CD4/ CD25, CD8/CD25 and CD4/CD25/FoxP3 by direct immune-fluorescence using primary conjugated monoclonal antibodies (BD Pharmingen, San Diego, CA, USA; eBioscience, San Diego, CA, USA) and flow cytometry (FACSCanto, Becton Dickinson, San Jose, CA, USA). Cells were then treated with the following TH9402 concentrations: 2.5, 3.0, 4.0, 5.0 and 10 mM. TH9402 incorporation was measured by flow cytometry, using the median fluorescence index. The higher the median fluorescence index, the lesser the light (measured in joules) emitted by the device and vice versa. We selected median fluorescence index from 10 000 to 30 000; energy delivery ranged between 0.1 and 10 J/cm 2 at a constant wavelength of 514 nm. Treated cells were cultured for 3 days to completely eliminate TH9402. Viability was confirmed by Trypan blue staining, flow cytometry and limiting-dilution analyses (LDA). Cells were phenotyped for CD4, CD8, CD3, CD4/CD25, CD8/CD25 and CD4/CD25/FoxP3 by direct immune-fluorescence, as described above.
LDA to assess Alloreactive CD4 þ T-cell depletion. Recipient PBMC were irradiated with 20 Gy and plated in 96-well U-bottomed plates at a concentration of 2 Â 10 6 /mL, that is, 2 Â 10 5 cells/well, in RPMI-1640 medium with 10% donor plasma. Donor (responder) cells were added to recipient (stimulator) cells at the following concentrations in groups of 48 wells for each dilution: control (untreated) donor cells: 1000 to 125 cells/well; allodepleted donor cells: 100 000 to 1250 cells/well. On day þ 14, IL-2 was added to cultures at the final concentration of 100 IU/mL. On days 14 --18, wells containing growing clones were counted by screening plates with an inverted microscope. Clones were assessed for CD3, CD4 and CD8 phenotype using primary conjugated monoclonal antibodies, as described above. After resting in IL-2-free medium for 24 h, alloreactivity was assessed by measuring DNA synthesis by H 
Alloreactive CD8
þ T-cell depletion. Recipient PBMC were irradiated and plated as above. Donor CD8 þ cells were separated by negative selection using anti-CD4 and anti-CD16 immune-magnetic beads (Miltenyi Biotec, Bergish Gladbach, Germany). Autologous irradiated (20 Gy) CD4 þ cells were added to cultures. CD8 þ cells (responder cells) were added to recipient (stimulator) cells at the following concentrations: control (untreated) and allodepleted donor cells: 100 000 to 1500 cells/well in groups of 24 wells for each dilution. On day þ 1 of culture, IL-2 was added at the final concentration of 0.5 IU/mL. On days þ 10 and þ 14, the IL-2 concentration was raised to respectively, 1.0 IU/mL and 20 IU/mL and cultures were re-stimulated with irradiated (20 Gy) recipient cells. Between days þ 18 and þ 21, wells containing growing clones were counted by screening plates with an inverted microscope. Clones were assessed for CD3, CD4 and CD8 phenotype as described. Alloreactivity was assessed by standard 51 Cr release cytotoxicity at an effector-to-target ratio of 10:1 against recipient PHA lymphoblasts. Clones exhibiting X30% lysis were scored as alloreactive.
Pathogen-and leukemia-specific responses in CD4
þ T cells. Donor PBMC to be used as APCs were irradiated, plated as above and pulsed with CMV, Aspergillus fumigatus (A. fumigatus) conidia, Candida albicans (C. albicans) yeasts, Toxoplasma gondii (T. gondii), HSV, ADV (Adenovirus) and VZV Ags, or with leukemia Ags WT-1 (ref. 14) and Ca125. 15 Control and allodepleted donor (responder) cells were plated on irradiated, Ag-pulsed cells at concentrations of 10 000 to 125 cells/well for CMV-, C. albicans-, T. gondii-, HSV-, ADV-and VZV-and WT-1-and Ca125-specific responses, and at concentrations of 100 000 to 3500 for A. fumigatus-specific responses. CMV, T. gondii, HSV and ADV Ags were purchased from Microbix Biosystems Inc (Toronto, Canada). As VZV Ag, we used commercial vaccine (Varivax, Sanofi Pasteur, Lyon, France). Heat-inactivated A. fumigatus conidia and C. albicans yeasts were provided by the Microbiology Division, University of Perugia. HLA-A201-restricted WT-1 126-134 peptide was synthesized by PRIMM, Milan, Italy. Ca125 Ag was purchased from Biodesign International, Saco, Maine, USA. On day þ 14 of culture, IL-2 was added at a 100 IU/mL final concentration. On days 14 --18, wells containing growing clones were counted by screening plates with an inverted microscope. Clones were assessed for CD3, CD4 and CD8 phenotype, as described. After resting in IL-2-free medium for 24 h, pathogen specificity was assessed by re-stimulating clones with pathogenpulsed irradiated donor PBMC for 3 days. DNA synthesis was measured by H 3 -thymidine uptake, as described. In other experiments, T-cell clonal supernatants were collected for cytokine content ELISA assay (Pierce SearchLight Products, Thermo Fisher Scientific, Woburn, MA, USA). 
Pathogen-and leukemia-specific responses in CD8
þ T cells. Donor PBMC were irradiated, plated as described and pulsed with CMV, T. gondii, HSV, ADV, VZV, WT-1 and Ca125. Donor CD8 þ cells were separated by negative selection using anti-CD4 and anti-CD16 immune-magnetic beads, as described. Control and allodepleted CD8 þ donor cells (responders) were plated on irradiated, Ag-pulsed cells at concentrations of 40 000 to 1250 cells/well. On day þ 1 of culture, IL-2 was added to a 0.5 IU/mL final concentration. On days þ 10 and þ 14, the IL-2 concentration was raised to respectively, 1.0 IU/mL and 20 IU/mL. Between days þ 18 and þ 21, wells containing growing clones were counted by screening plates with an inverted microscope. Clones were assessed for CD3, CD4 and CD8 phenotype as described. Ag-specificity of CD8 þ clones was assessed by IFN-g Elispot assay (Nanogen Advanced Diagnostic, San Diego, CA, USA).
MLR proliferative activity. MLR proliferation was assessed by stimulating cells with irradiated donor PBMC (as negative control), irradiated stimulator PBMC, or 1% PHA (as positive control). DNA synthesis was measured by H 3 -thymidine uptake as described above.
RESULTS
Allodepletion protocol. We confirmed reported conditions 13 were reliable and reproducible, providing optimal allodepletion and retention of pathogen-and leukemia-specific T-cell response. These conditions provided 3854 ± 1054 fold-reduction in alloreactive T-cell precursors in mismatched pairs, 2408 ± 1110 foldalloreduction in matched pairs, retention of pathogen-and leukemia-specific T-cell responses, although reduced by 19 ± 9.7-fold and 5 ± 2-fold, respectively. Activation marker expression (CD25) did not differ with the duration of MLR culture (1 --5 days) (data not shown). Cytokine production by pathogen-specific T-cell clones was not affected by the photodynamic treatment (Figure 1) . Functional analyses showed a protective T-helper (Th) 1/T-regulatory (IFN-g, IL-10 and IL-17 production, low IL-4) profile against infectious pathogens. Pre-and post-treatment phenotyping showed photodynamic purging eliminated activated CD4
þ /FoxP3 þ regulatory T cells, as described.
13
LDA measures alloreduction more sensitively than immune phenotyping and H 3 -thymidine incorporation. Immune phenotyping of MLR for CD25 expression and LDA of alloreactive T-cell precursors were compared before and after photodynamic purging. Immune phenotyping by flow cytometry always showed the same reduction in frequencies of alloreactive T cells. When measured by LDA, frequencies were reduced by B10-fold, B100-fold and B1000-fold. These data indicate that flow cytometry is less sensitive and reliable than LDA in measuring the alloreactive T-cell repertoire (Figure 2) . H 3 -thymidine incorporation of MLR was compared with LDA of alloreactive T-cell precursors. H 3 -thymidine incorporation always showed the same reduction in frequencies of alloreactive T cells, as measured by c.p.m. When measured by LDA, frequencies were reduced by B10-fold, B100-fold and B1000-fold. These data indicate that H 3 -thymidine incorporation is less sensitive and reliable than LDA in measuring the alloreactive T-cell repertoire (Figure 3) .
Photodynamic treatment procedure also reduced the frequency of pathogen-and leukemia-specific responses. Increases in allodepletion (from B10-fold to B100-fold to B1000-fold) did not affect the frequency of pathogen (CMV, A. fumigatus)-specific responses (Figure 4) .
DISCUSSION
It is a well-accepted fact that any attempt to provide adoptive T-cell therapy for adult haploidentical transplant recipients needs to eliminate alloreactive T cells from the donor lymphocyte infusion. 13 The present study corroborated and completed our investigations into photodynamic purging as a safe and effective procedure for adoptive T-cell therapy for haploidentical stem cell transplant recipients. Although it appears to be effective, one could object it is not an innovative strategy. Ongoing clinical trials have demonstrated the feasibility and efficacy of donor photoallodepleted T-cell transfer in allogeneic transplant recipients. 16 --18 In the haploidentical transplant setting, however, these infusions were followed by a relatively high incidence of acute grade I --II and chronic GVHD, which required immune-suppressive treatment. 19 Onset of this complication was probably due to the alloreactive T-cell repertoire, which cannot be reliably quantified due to lack of a suitable method.
The present study not only identified conditions for optimal allodepletion with retention of pathogen-and leukemia-specific responses but also showed LDA was a sensitive, reliable method for accurately quantifying alloreactive and Ag-specific T-cell repertoires. We achieved about 3000-fold reduction in alloreactivity in matched and haploidentical pairs, which is much more than reported in other studies. 10 --12,16 --19 Such an extensive reduction in the frequency of alloreactive T-cell precursors might allow infusion of high doses of donor T cells across the HLA barrier without causing GVHD. Pathogen-specific T-cell clones were obtained by LDA, before and after photodynamic purging, as described. T-cell clonal supernatants were collected to determine cytokine content with ELISA SearchLight assay. We measured IFN-g (closed bars), IL-10 (hatched bars), IL-17 (open bars) and IL-4 (striped bars) levels and we did not observe differences before (upper panel) and after (bottom panel) the treatment. Moreover, these pathogen-specific T-cell clones displayed protective/T-regulatory cytokine profiles, which were characterized by high levels of IFN-g and IL-10 (pg/mL), and low levels of IL-17 and IL-4 (pg/mL). We observed that immune phenotyping by flow cytometry always showed the same reduction in frequencies of alloreactive T cells, whereas, when measured by LDA, frequencies were reduced by B10-fold (a), B100-fold (b) and B1000-fold (c).
Our method preserved pathogen-and leukemia-specific T-cell responses, as measured by LDA. LDA analyzed clonal T CD4 þ and CD8 þ repertoires against different pathogens and leukemic Ags before and after photodynamic treatment. Results are expressed as frequency numbers, immune phenotype and cytokine production. Responses were reduced by up to 10-fold, demonstrating that photodynamic treatment preserved a functional, polyclonal T-cell repertoire and not just CMV-and anti-third party-specific T-cell responses as reported by others. 10,11,17 --19 LDA was compared with H Cytokine production analyses showed T-cell responses were functional and protective as they produced IFN-g, IL-10 and IL-17. Production of IFN-g indicated a protective T-cell response to pathogens. Release of IL-10 showed presence of a T-regulatory response, which might mitigate inflammation. Finally, although IL-17 is known to impair immune response against pathogens, recent evidence showed that it played a role in resistance to infections when in association with IFN-g and IL-10. 20, 21 In conclusion, this study demonstrated for the first time that photodynamic purging of alloreactive T cells combined with LDA was a reliable test for measuring allodepletion, served as a quality control of large-scale dry-runs and was an innovative and promising approach for adoptive immunotherapy after allo-SCT.
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The authors declare no conflict of interest. Figure 3 . LDA is more sensitive than thymidine incorporation to measure the degree of allodepletion after photodynamic purging of alloreactive T cells. Alloreactive T-cell clones were obtained by LDA before and after photodynamic purging, as described. We compared H 3 -thymidine incorporation by MLR cells before and after the treatment. Briefly, MLR cells were stimulated with irradiated autologous (donor) PBMC (negative control, closed bars), with 1% PHA (positive control, open bars), and with irradiated recipient PBMC (hatched bars). We observed that H 3 -thymidine incorporation by MLR cells always showed the same reduction in frequencies of alloreactive T cells, whereas, when measured by LDA, frequencies were reduced by B10-fold (a), B100-fold (b) and B1000-fold (c). þ T-cell clones were obtained by LDA before (closed bars) and after (open bars) photodynamic purging, as described. We observed that frequencies of A. fumigatus-specific CD4 þ T-cell clones (upper panels) showed the same degree of reduction across B10-fold (a), B100-fold (b) and B1000-fold (c) reduction in alloreactivity as measured by LDA. Also frequencies of CMV-specific CD4 þ T-cell clones (bottom panels) showed the same degree of reduction across B10-fold (d), B100-fold (e) and B1000-fold (f ) reduction in alloreactivity as measured by LDA.
